Broadly protective bispecific antibodies that simultaneously target influenza hemagglutinin and neuraminidase

Here, the investigators engineered bispecific antibodies (bsAbs) combining the variable domains of CR9114 and 1G01, and evaluated their properties in vitro and in vivo.